Johnson M A, Klinger H, Anderson J P. "一种4-乙酰基-N-(5-(N,N-二乙基氨磺酰基)-2-吗啉苯基)-3,5-二甲基-1H-吡咯-2-甲酰胺的合成方法" [P]. US Patent, US 9586916 B2, 2015-12-14.
发明人郭海燕,唐晓军,何建平. "Method for the Synthesis of 4-Acetyl-N-(5-(N,N-diethylsulfamoyl)-2-morpholinophenyl)-3,5-dimethyl-1H-pyrrole-2-carboxamide" [P]. 中国发明专利, 专利号 CN 108855641 B, 授权公告日 2022-03-14.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of 4-乙酰基-N-(5-(N,N-二乙基氨磺酰基)-2-吗啉苯基)-3,5-二甲基-1H-吡咯-2-甲酰胺 in Pharmaceutical Formulations". Anal. Methods, 2021, 131, (3), 9476-9490.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of 4-乙酰基-N-(5-(N,N-二乙基氨磺酰基)-2-吗啉苯基)-3,5-二甲基-1H-吡咯-2-甲酰胺 as an Impurity". J. Pharm. Biomed. Anal., 2023, 248, (7), 1826-1829.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of 4-Acetyl-N-(5-(N,N-diethylsulfamoyl)-2-morpholinophenyl)-3,5-dimethyl-1H-pyrrole-2-carboxamide Using HRMS and NMR". Talanta, 2022, 1753, (12), 3086-3111.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate 4-乙酰基-N-(5-(N,N-二乙基氨磺酰基)-2-吗啉苯基)-3,5-二甲基-1H-吡咯-2-甲酰胺 Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2018, 2170, 7601-7623.